139
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients

, ORCID Icon, & ORCID Icon
Pages 3495-3507 | Published online: 31 Aug 2021

References

  • Henriquez-CamachoC, LosaJ. Biomarkers for sepsis. Bio Med Res Int. 2014;ID 547818:1–6.
  • BalkR. The evolving paradigms of sepsis. Contrib Microbiol. 2011;17:1–11.21659744
  • FaixJD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50(1):23–36. doi:10.3109/10408363.2013.76449023480440
  • GodnicM, StubjarD, SkvarcM, JukicT. Diagnostic and prognostic value of sCD14‑ST presepsin for patients admitted to hospital intensive care unit. Wien Klin Wochenschr. 2015;127:521–527. doi:10.1007/s00508-015-0719-525854904
  • BironBM, AyalaA, Lomas-NeiraJL. Biomarkers for sepsis: what is and what might be?Biomark Insights. 2015;10(4):7–17.26417200
  • AtallaHA, AbdelazizAA, RagabAM. Biomarkers in sepsis: review article. Menoufia Med J. 2018;31(4):1110–1115.
  • EricksonSE, MartinGS. Effect of sepsis therapies on health‑related quality of life. Crit Care. 2008;12(1):109. doi:10.1186/cc621518254930
  • WangB, ChenG, ZhangJ, XueJ, CaoY, WuY. Increased neutrophil gelatinase associated lipocalin is associated with mortality and multiple organ dysfunction syndrome in severe sepsis and septic shock. Shock. 2015;44(3):234–238. doi:10.1097/SHK.000000000000040826009825
  • JedynakM, SiemiatkowskiA, MroczkoB, GroblewskaM, MilewskiR, SzmitkowskiM. Soluble TREM-1 serum level can early predict mortality of patients with sepsis, severe sepsis and septic shock. Arch Immunol Ther Exp. 2018;66(4):299–306. doi:10.1007/s00005-017-0499-x
  • CaoC, GuJ, ZhangJ. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases. Front Med. 2017;11(2):169–177. doi:10.1007/s11684-017-0505-z28425045
  • GustafssonA, LjunggrenL, BodelssonM, BerkestedtI. The prognostic value of suPAR compared to other inflammatory markers in patients with severe sepsis. Biomark Insights. 2012;7:39–44. doi:10.4137/BMI.S946022550400
  • JedynakM, SiemiatkowskiA, MilewskiR, MroczkoB, SzmitkowskiM. Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1 in sepsis, severe sepsis and septic shock. Arch Med Sci. 2019;15(3):713–721. doi:10.5114/aoms.2018.7309031110539
  • ŞenS, KamitF, IşgüderR, et al. Surface TREM-1 as a prognostic biomarker in pediatric sepsis. Indian J Pediatr. 2021;88(2):134–140. doi:10.1007/s12098-020-03355-332572693
  • LeeCC, HongMY, LeeNY, ChenPL, ChangCM, KoWC. Pitfalls in using serum C-reactive protein to predict bacteremia in febrile adults in the ED. Am J Emerg Med. 2012;30(4):562–569. doi:10.1016/j.ajem.2011.02.01221514766
  • Rivera-ChavezFA, MineiJP. Soluble triggering receptor expressed on myeloid cells-1 is an early marker of infection in the surgical intensive care unit. Surg Infect (Larchmt). 2009;10(5):435–439. doi:10.1089/sur.2009.03019792836
  • SuL, HanB, LiuB, et al. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis. 2012;12:157. doi:10.1186/1471-2334-12-15722809118
  • OkuR, OdaS, NakadaT, et al. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Cytokine. 2013;61(1):112–117. doi:10.1016/j.cyto.2012.09.00323046618
  • ChangW, PengF, MengSS, XuJY, YangY. Diagnostic value of serum soluble triggering expressed receptor on myeloid cells 1 (sTREM-1) in suspected sepsis: a meta-analysis. BMC Immunol. 2020;21(2):1–3. doi:10.1186/s12865-020-0332-x31898481
  • ZhangJ, SheD, FengD, JiaY, XieL. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study. BMC Infect Dis. 2011;11:53. doi:10.1186/1471-2334-11-5321356122
  • LiZ, WangH, LiuJ, ChenB, LiG. Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study. Mediators Inflamm. 2014;ID 641039:7.
  • ZhangL, ZhangX. Serum sTREM-1, PCT, CRP, Lac as biomarkers for death risk within 28 days in patients with severe sepsis. Open Life Sci. 2018;13:42–47. doi:10.1515/biol-2018-000633817066
  • Giamarellos-BourboulisEJ, Norrby-TeglundA, MylonaV, et al. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor. Crit Care. 2012;16(4):149–159. doi:10.1186/cc1146322963733
  • KochA, VoigtS, KruschinskiC, et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care. 2011;15(1):R63. doi:10.1186/cc1003721324198